January 29, 2018 / 7:08 AM / 8 months ago

BRIEF-SyntheticMR Gets Regulatory Clearance From FDA‍​

Jan 29 (Reuters) - SYNTHETICMR AB (PUBL):

* SEGMENTATION AND QUANTIFICATION OF BRAIN TISSUE, AND INDUSTRY FIRST MYELIN VOLUME MEASUREMENTS IN SYMRI NOW FDA CLEARED‍​

* SYNTHETICMR AB (PUBL) - SAYS ‍SYMRI AS A WHOLE CAN NOW BE OFFERED TO CLINICS AND HOSPITALS ON US MARKET. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below